0001179110-19-013022.txt : 20191218 0001179110-19-013022.hdr.sgml : 20191218 20191218184120 ACCESSION NUMBER: 0001179110-19-013022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191216 FILED AS OF DATE: 20191218 DATE AS OF CHANGE: 20191218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheena Jonathan CENTRAL INDEX KEY: 0001646649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 191293725 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 edgar.xml FORM 4 - X0306 4 2019-12-16 0 0001604821 Natera, Inc. NTRA 0001646649 Sheena Jonathan C/O NATERA, INC., 201 INDUSTRIAL ROAD SUITE 410 SAN CARLOS CA 94070 1 1 0 0 Chief Technology Officer Common Stock 2019-12-16 4 M 0 37481 2.6569 A 280267 D Common Stock 2019-12-16 4 S 0 37281 37.6853 D 242986 D Common Stock 2019-12-16 4 S 0 200 38.0050 D 242786 D Common Stock 2019-12-16 4 M 0 62519 5.3953 A 305305 D Common Stock 2019-12-16 4 S 0 62219 37.6969 D 243086 D Common Stock 2019-12-16 4 S 0 300 38.0200 D 242786 D Stock Option (right to buy) 2.6569 2019-12-16 4 M 0 37481 0 D 2024-02-25 Common Stock 37481 0 D Stock Option (right to buy) 5.3953 2019-12-16 4 M 0 62519 0 D 2024-12-09 Common Stock 62519 60180 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vested fully and became exercisable on February 25, 2014. The option shares vested fully and became exercisable on November 20,2019. /s/ Tami Chen, attorney-in-fact 2019-12-18